Shotaro Tatekawa Selected Research

Shotaro Tatekawa Research Topics

Disease

14	Neoplasms (Cancer) 04/2024 - 11/2013
4	Pancreatic Neoplasms (Pancreatic Cancer) 04/2024 - 01/2022
4	Adenocarcinoma 03/2024 - 01/2022
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2024 - 09/2019
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2015 - 11/2013
2	Neoplasm Metastasis (Metastasis) 04/2024 - 01/2022
2	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 12/2015
2	Genetic Translocation (Chromosomal Translocation) 01/2022 - 01/2016
1	Squamous Cell Carcinoma of Head and Neck 02/2024
1	Hemorrhage 11/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2022
1	Osteosarcoma (Osteogenic Sarcoma) 01/2022
1	Tetraploidy 01/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 10/2021
1	Carcinoma (Carcinomatosis) 05/2021
1	Alzheimer Disease (Alzheimer's Disease) 09/2019
1	Chromosome Aberrations (Chromosome Abnormalities) 05/2017
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 05/2017
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2016
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2016
1	Bacterial Pneumonia 01/2016
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2016
1	Ascites 06/2015
1	Multi-centric Castleman's Disease 06/2015
1	Multiple Myeloma 04/2015
1	Bronchiolitis Obliterans Syndrome 01/2014
1	Autoimmune Pancreatitis 01/2014
1	Pancreatitis 01/2014
1	Carcinogenesis 11/2013
1	Acromegaly 11/2013
1	Pituitary Neoplasms (Pituitary Adenoma) 11/2013

Drug/Important Bio-Agent (IBA)

3	6-methyladenineIBA 04/2024 - 01/2022
3	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2022
3	RNA (Ribonucleic Acid)IBA 08/2022 - 10/2021
3	Radiation-Sensitizing AgentsIBA 01/2022 - 09/2019
2	Messenger RNA (mRNA)IBA 04/2024 - 01/2022
2	Prednisolone (Predate)FDA LinkGeneric 01/2016 - 06/2015
2	Bortezomib (Velcade)FDA Link 01/2016 - 04/2015
1	EnzymesIBA 04/2024
1	NeuropilinsIBA 03/2024
1	Neuropilin-1IBA 03/2024
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2024
1	B7-H1 AntigenIBA 02/2024
1	NexusIBA 01/2024
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Granzymes (Granzyme)IBA 01/2022
1	Circular RNAIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Insulin-Like PeptidesIBA 01/2022
1	Polo-Like Kinase 1IBA 01/2022
1	3' Untranslated Regions (3' UTR)IBA 01/2022
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	olaparibIBA 01/2022
1	veliparibIBA 01/2022
1	N- (oxo- 5,6- dihydrophenanthridin- 2- yl)- N,N- dimethylacetamide hydrochlorideIBA 01/2022
1	MethyltransferasesIBA 01/2022
1	N-methyladenosineIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Niacinamide (Nicotinamide)FDA LinkGeneric 10/2021
1	CarbonIBA 10/2021
1	S-Adenosylmethionine (Ademetionine)IBA 10/2021
1	CotinineIBA 05/2021
1	Carbon MonoxideIBA 05/2021
1	dihydroouabainIBA 01/2020
1	Amyloid (Amyloid Fibrils)IBA 09/2019
1	(2'- (4- aminophenyl)- (2,5'- bi- 1H- benzimidazol)- 5- amine)IBA 09/2019
1	Rituximab (Mabthera)FDA Link 05/2017
1	RHO(D) antibody (anti-D)IBA 01/2016
1	AutoantibodiesIBA 01/2016
1	Lenalidomide (CC 5013)FDA Link 01/2016
1	AntigensIBA 01/2016
1	Netrin-1IBA 12/2015
1	Thalidomide (Thalomid)FDA Link 06/2015
1	tocilizumab (atlizumab)FDA Link 06/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2014
1	Gabexate (Foy)IBA 01/2014
1	Insulin-Like Growth Factor I (IGF-1)IBA 11/2013
1	Growth Hormone (Somatotropin)IBA 11/2013

Therapy/Procedure

9	Radiotherapy 02/2024 - 01/2020
7	Therapeutics 03/2024 - 04/2015
2	Drug Therapy (Chemotherapy) 04/2022 - 11/2013
2	Transplantation 01/2016 - 01/2015
1	Immunotherapy 04/2022
1	Radiation Dose Fractionation 01/2022
1	Cell Transplantation 01/2016
1	Hematopoietic Stem Cell Transplantation 01/2015
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2014